Literature DB >> 21336475

Novel and recurrent FERMT1 gene mutations in Kindler syndrome.

Tanasit Techanukul1, Gomathy Sethuraman, Abraham Zlotogorski, Liran Horev, Michal Macarov, Alison Trainer, Kenneth Fong, Marko Lens, Ljiljana Medenica, Venkatesh Ramesh, John A McGrath, Joey E Lai-Cheong.   

Abstract

Kindler syndrome (OMIM 173650) is an autosomal recessive condition characterized by skin blistering, skin atrophy, photosensitivity, colonic inflammation and mucosal stenosis. Fewer than 100 cases have been described in the literature. First reported in 1954, the molecular basis of Kindler syndrome was elucidated in 2003 with the discovery of FERMT1 (KIND1) loss-of-function mutations in affected individuals. The FERMT1 gene encodes kindlin-1 (also known as fermitin family homologue 1), a 77 kDa protein that localizes at focal adhesions, where it plays an important role in integrin signalling. In the current study, we describe five novel and three recurrent loss-of-function FERMT1 mutations in eight individuals with Kindler syndrome, and provide an overview of genotype-phenotype correlation in this disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336475     DOI: 10.2340/00015555-1063

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  8 in total

1.  Kindler syndrome: a close mimic of dyskeratosis congenita and the need to distinguish the two clinical entities.

Authors:  Shailendra Kapoor
Journal:  Oman Med J       Date:  2014-03

2.  Genome-wide association study for posthitis in the free-living population of European bison (Bison bonasus).

Authors:  Kamil Oleński; Małgorzata Tokarska; Dorota Hering; Paulina Puckowska; Anna Ruść; Cino Pertoldi; Stanisław Kamiński
Journal:  Biol Direct       Date:  2015-01-14       Impact factor: 4.540

3.  Kindler syndrome: a rare case report from Greece.

Authors:  Maria Gkaitatzi; Evangelia Kalloniati; Cristina Has; Dimitra Kiritsi; Theofanis Spiliopoulos; Sophia Georgiou
Journal:  Oxf Med Case Reports       Date:  2019-02-25

Review 4.  Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting.

Authors:  Jiansong Huang; Xia Li; Xiaofeng Shi; Mark Zhu; Jinghan Wang; Shujuan Huang; Xin Huang; Huafeng Wang; Ling Li; Huan Deng; Yulan Zhou; Jianhua Mao; Zhangbiao Long; Zhixin Ma; Wenle Ye; Jiajia Pan; Xiaodong Xi; Jie Jin
Journal:  J Hematol Oncol       Date:  2019-03-07       Impact factor: 17.388

5.  Assessment of the risk and characterization of non-melanoma skin cancer in Kindler syndrome: study of a series of 91 patients.

Authors:  Sara Guerrero-Aspizua; Claudio J Conti; Maria Jose Escamez; Daniele Castiglia; Giovanna Zambruno; Leila Youssefian; Hassan Vahidnezhad; Luis Requena; Peter Itin; Gianluca Tadini; Ivelina Yordanova; Ludovic Martin; Jouni Uitto; Cristina Has; Marcela Del Rio
Journal:  Orphanet J Rare Dis       Date:  2019-07-24       Impact factor: 4.123

Review 6.  Novel Discoveries in Immune Dysregulation in Inborn Errors of Immunity.

Authors:  Anwen Ren; Wei Yin; Heather Miller; Lisa S Westerberg; Fabio Candotti; Chan-Sik Park; Pamela Lee; Quan Gong; Yan Chen; Chaohong Liu
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

7.  Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.

Authors:  Susanne Krämer; James Lucas; Francisca Gamboa; Miguel Peñarrocha Diago; David Peñarrocha Oltra; Marcelo Guzmán-Letelier; Sanchit Paul; Gustavo Molina; Lorena Sepúlveda; Ignacio Araya; Rubén Soto; Carolina Arriagada; Anne W Lucky; Jemima E Mellerio; Roger Cornwall; Fatimah Alsayer; Reinhard Schilke; Mark Adam Antal; Fernanda Castrillón; Camila Paredes; Maria Concepción Serrano; Victoria Clark
Journal:  Spec Care Dentist       Date:  2020-11

8.  Kindlin-1 Regulates Epidermal Growth Factor Receptor Signaling.

Authors:  Magdalene Michael; Rumena Begum; Grace K Chan; Austin J Whitewood; Daniel R Matthews; Benjamin T Goult; John A McGrath; Maddy Parsons
Journal:  J Invest Dermatol       Date:  2018-09-21       Impact factor: 8.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.